FDA approval of this game-changing COVID-19 test developed by New York’s Upstate Medical and Quadrant Biosciences will be leveraged on a national scale. It is a quick, noninvasive testing protocol to help communities across the country better pinpoint and contain COVID-19. The approved tests can be conducted using saliva swabs rather than swabs inserted in a person’s nose. Individuals administer the tests themselves, swabbing their mouths, and provide the saliva samples, which are currently processed at SUNY Upstate Medical Center’s laboratory.
